ConductScience.org, home

Paper1804644

Hemodynamic effects of Ro 23-6152 in patients with essential hypertension.

Folkers HB and 4 others. Eur J Clin Pharmacol, 1991. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Hemodynamic effects of Ro 23-6152 in patients with essential hypertension. Papers, record 1804644. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/1804644

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Hemodynamic effects of Ro 23-6152 in patients with essential hypertension.
PubMed
Journal
Eur J Clin Pharmacol
PubMed
Year
1991
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
0
iCite
Relative citation ratio, by iCite
0
iCite
Revised in PubMed
2018-11-13
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Folkers HBH B
2van Zwienen JCJ C
3Boer PP
4Kleinbloesem CHC H
5Geyskes GGG G

Source PubMed

Download CSV of authors

Topics16

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antihypertensive AgentsMajor topic
DiltiazemMajor topic
HemodynamicsMajor topic
HypertensionMajor topic
Adult
Blood Pressure
Cardiac Output
Double-Blind Method
Electrocardiography
Female
Heart Rate
Humans
Male
Middle Aged
Stroke Volume
Vascular Resistance

Source PubMed

Download CSV of topics

References18

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
1913018Nifedipine, a new antihypertensive with rapid action.Clin Pharmacol Ther1977https://conductscience.org/library/papers/913018PubMed
2371856Treatment of hypertension with nifedipine, a calcium antagonistic agent.Circulation1979https://conductscience.org/library/papers/371856PubMed
37053285The 24-hour ambulatory blood pressure profile with verapamil.Circulation1982https://conductscience.org/library/papers/7053285PubMed
4966384Hypotensive action and increased plasma renin activity by Ca2+ antagonist (Nifedipine) in hypertensive patients.Jpn Heart J1976https://conductscience.org/library/papers/966384PubMed
53568303Cardiovascular effects of verapamil in patients with essential hypertension.Circulation1987https://conductscience.org/library/papers/3568303PubMed
66831651Role of calcium antagonists in the treatment of essential hypertension.Circ Res1983https://conductscience.org/library/papers/6831651PubMed
7455134The effect of Ca2+ antagonists on mechanical responses and Ca2+ movements in guinea pig ileal longitudinal smooth muscle.Can J Physiol Pharmacol1979https://conductscience.org/library/papers/455134PubMed
86587749Hemodynamic effects of verapamil in essential hypertension at rest and during exercise.Acta Med Scand Suppl1984https://conductscience.org/library/papers/6587749PubMed
96345376Calcium and blood pressure regulation in normal and hypertensive subjects.Hypertension1983https://conductscience.org/library/papers/6345376PubMed
10989421Hemodynamic effects caused by i.v. administration of verapamil in healthy subjects.Arzneimittelforschung1976https://conductscience.org/library/papers/989421PubMed
113284572Is the measurement of cardiac output useful in clinical practice?Br J Anaesth1988https://conductscience.org/library/papers/3284572PubMed
126156334Comparison of acute effects of nifedipine in normotensive and hypertensive man.J Cardiovasc Pharmacol1980https://conductscience.org/library/papers/6156334PubMed
137030005Calcium blockade as a therapeutic principle in arterial hypertension. Clinical aspects and experimental studies on isolated vessels from spontaneously hypertensive rats and normotensive man.Acta Pharmacol Toxicol (Copenh)1981https://conductscience.org/library/papers/7030005PubMed
146821902Noninvasive Doppler determination of cardiac output in man. Clinical validation.Circulation1983https://conductscience.org/library/papers/6821902PubMed
152525830A new approach to the noninvasive measurement of cardiac output using an annular array Doppler technique--I. Theoretical considerations and ultrasonic fields.Ultrasound Med Biol1989https://conductscience.org/library/papers/2525830PubMed
163891302Diltiazem. A review of its pharmacological properties and therapeutic efficacy.Drugs1985https://conductscience.org/library/papers/3891302PubMed
176637817Effects of diltiazem on cardiovascular responses during exercise in systemic hypertension and comparison with propranolol.Am J Cardiol1983https://conductscience.org/library/papers/6637817PubMed
18696343Effects of extracellular calcium on potassium and noradrenaline induced contractions in the aorta of spontaneously hypertensive rats--increased sensitivity to nifedipine.Acta Pharmacol Toxicol (Copenh)1978https://conductscience.org/library/papers/696343PubMed

Download CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/1804644

GET https://conductscience.org/api/papers/v1/1804644/authors